ACTRN12609000442202
Terminated
未知
A randomised controlled trial to assess whether the use of physiologic testing to guide intensity of a Heart Failure Management Program (including the combination of isosorbide mononitrate and hydralazine to the contemporary medical regimen) leads to better outcomes over 2 years follow-up.
ational Health and Medical Research Council0 sites360 target enrollmentJune 12, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Health and Medical Research Council
- Enrollment
- 360
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \>\=40 years
- •Diagnosis of Heart Failure
- •Not suitable for cardiac resynchronisation therapy
- •Not suitable for revascularisation
Exclusion Criteria
- •Suitable for revascularisation
- •Suitable for cardiac resynchronisation therapy
- •No diagnosis of heart failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
ART & DEMENTIA: Does an art program enhance wellbeing and markers of neuroplasticity in people with dementia?DementiaCognitive DeclineMental Health - Studies of normal psychology, cognitive function and behaviourNeurological - DementiasNeurological - Alzheimer's diseaseACTRN12616000100493niversity of Sydney120
Completed
Not Applicable
SOMNA: Sleep Or Mood Novel Adjunctive therapy. The effectiveness of an adjunctive internet Cognitive Behavioural Therapy (CBT) intervention for insomnia in older men with depression.DepressionAnxietyInsomniaMental Health - DepressionMental Health - AnxietyMental Health - Other mental health disordersACTRN12612000985886The University of Sydney80
Active, not recruiting
Not Applicable
Evaluation of an internet-delivered program for risky alcohol use in older adultsHazardous and harmful alcohol useMental Health - AddictionPublic Health - Health service researchPublic Health - Health promotion/educationACTRN12621000292875SW Sydney888
Completed
Not Applicable
Zoledronate to prevent bone loss in acute multiple sclerosisMultiple sclerosisNervous System DiseasesISRCTN87039596orth Bristol NHS Trust (UK)40
Completed
Not Applicable
Risedronate for the prevention of bone loss after steroid therapy for a flare-up in inflammatory bowel diseaseInflammatory bowel disease (ulcerative colitis and Crohn's disease)Digestive SystemNoninfective inflammatory bowel diseaseISRCTN93280043niversity Hospitals Bristol NHS Foundation Trust (UK)100